Las Vegas, NV -- (SBWIRE) -- 12/24/2013 -- PennyStockEarnings team record for picking gainers is one of the best in the business, and our followers continue to make substantial profits – even in bear markets. Our Team includes top analysts and use level II screeners to get you the information you need to make intelligent decisions for trading penny stocks. Our Today’s Focus is on: Coronado Biosciences Inc (NASDAQ:CNDO), Infinera Corp. (NASDAQ:INFN), Turquoise Hill Resources Ltd (NYSE:TRQ), Mast Therapeutics Inc (NYSEMKT:MSTX)
Coronado Biosciences Inc (NASDAQ:CNDO) managed to keep its gain at 5.74% on below -normal volume of 1.05M shares. The stock settled at $2.21 after floating in a range of $2.09 to $2.21. Its latest price has reached market capitalization of $75.02 million. Its 52-week range has been $1.25 to $12.70. Coronado Biosciences, Inc. is a biopharmaceutical company focused on the development of novel immunotherapy biologic agents for the treatment of autoimmune diseases and cancer.
For How Long CNDO will fight for Profitability? Read This Trend Analysis report
Infinera Corp. (NASDAQ:INFN) traded up on a volume of 2.26 million, higher than its standard daily volume. Shares have gained 3.85% to $9.58. Over the last twelve months, the stock has gained 61.28% and faced a worst price of $5.66. nfinera Corporation (Infinera) provides optical networking equipment, software and services to communications service providers, Internet content providers, cable operators and subsea network operators (collectively, Service Providers) across the globe.
For How Long INFN’s Gloss will Attract Investors? Find out via this report
Turquoise Hill Resources Ltd (NYSE:TRQ) settled 2.20% higher at $3.25 on above-normal volume of 7.76M shares during the last trading day. The stock has its 12-month high at $9.62 and 52-week low price was $3.03. It traded in a range of $3.19 to $3.28 during the last trading day. Turquoise Hill Resources Ltd., formerly Ivanhoe Mines Ltd. is an international mineral exploration and development company. The Company’s principal mineral resource property is the Oyu Tolgoi Project, located in Mongolia.
Why Should Investors Buy TRQ After the Recent Fall? Just Go Here and Find Out
In the last trading session, Mast Therapeutics Inc (NYSEMKT:MSTX) was up on low volume, trading at a volume of 1.04M shares versus its average daily volume of 1.10 million shares. At $0.430, the stock has attained market capitalization of $44.17 million. Mast Therapeutics, Inc., formerly ADVENTRX Pharmaceuticals, Inc., is a development-stage company biopharmaceutical company focused on developing product candidates. The Company's product candidate is ANX-188, a rheologic, antithrombotic and cytoprotective agent that improves microvascular blood flow and has application in treating a range of diseases and conditions, such as complications arising from sickle cell disease.
Will MSTX Continue To Move Higher? Find Out Here
PennyStockEarnings.com is keen to discover penny stocks with the potential to make short and long-term gains.
PSE Team record for picking gainers is one of the best in the business, and our followers continue to make substantial profits – even in bear markets. Our Team includes top analysts and use level II screeners to get you the information you need to make intelligent decisions for trading penny stocks.
PLEASE NOTE WELL: The employees of PennyStockEarnings.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockEarnings.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockEarnings.com is not offering securities for sale. Neither PennyStockEarnings.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockEarnings.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockEarnings.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer Here: http://www.pennystockearnings.com/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)